海外の治験の状況「1」での検索結果
1037件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
- Recurrent Head and Neck Cancer;Metastatic Head and Neck Cancer
- Argentina, Australia, Austria, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Latvia, Malaysia, Mexico, Netherlands, Norway, Peru, Philippines, Poland, Russian Federation, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Kingdom, United States
- 2015-02-03
Not recruiting
- Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma
- Cholangiocarcinoma;Cholangiocarcinoma;Cholangiocarcinoma
- Austria, United States
- 2014-07-02
Not recruiting
- Randomised phase 3 trial of enzalutamide in first line androgen deprivation therapy for metastatic prostate cancer: ENZAMET
- Prostate Cancer
- Australia, Canada, Ireland, New Zealand, United Kingdom, United States of America
- 2014-01-29
Not recruiting
- A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection
- Hepatitis C Virus Infection;Human Immunodeficiency Virus Infection;Chronic Hepatitis C;Compensated Cirrhosis and Non-cirrhotics;Hepatitis C Virus Infection;Human Immunodeficiency Virus Infection;Chronic Hepatitis C;Compensated Cirrhosis and Non-cirrhotics;Hepatitis C Virus Infection;Human Immunodeficiency Virus Infection;Chronic Hepatitis C;Compensated Cirrhosis and Non-cirrhotics;Hepatitis C Virus Infection;Human Immunodeficiency Virus Infection;Chronic Hepatitis C;Compensated Cirrhosis and Non-cirrhotics
- Australia, Canada, France, Germany, Italy, New Zealand, Puerto Rico, Russian Federation, Spain, United Kingdom, United States
- 2013-09-06
Not Recruiting
- Phase 1 clinical study to assess safety of single infusions of rADAMTS13 (BAX930) in humans and to evaluate distribution and elimination of rADAMTS13 (BAX930) from the human body after administration at 3 different dose levels in patients diagnosed with severe hereditary TTP
- Subjects diagnosed with hereditary thrombotic thrombocytopenic purpura (TTP) MedDRA version: 18.0 Level: LLT Classification code 10043562 Term: Thrombocytopenic purpura, thrombotic System Organ Class: 100000004851 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Austria, Germany, Japan, Poland, United Kingdom, United States
- 2012-11-12
Not recruiting
- Safety and Efficacy Study of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI as Second Line Therapy in Participants With KRAS Wild-Type Metastatic Colorectal Cancer (mCRC)
- Colorectal Cancer
- Australia, Belgium, France, Germany, Italy, New Zealand, Romania, Spain, United Kingdom, United States
- 2012-07-26
Not recruiting
- A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
- Colorectal Cancer;Colorectal Cancer;Colorectal Cancer;Colorectal Cancer
- Australia, Austria, Belgium, Canada, Czech Republic, Finland, Hungary, Italy, Netherlands, Spain, United Kingdom, United States
- 2011-11-21
Not recruiting
- Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy.
- Metastatic Colorectal Cancer
- Australia, Austria, Brazil, Denmark, Estonia, France, Ireland, Italy, Lithuania, Russian Federation, Spain, Sweden, United Kingdom
- 2018-02-23
Not recruiting
- Phase 2 Study of Enzastaurin With 5 FU/LV Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer
- Colorectal Cancer
- Austria, France, Germany, Italy, Portugal, Puerto Rico, United States
- 2008-01-28
Not Recruiting
- A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study of Enzastaurin with 5 FU/LV plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colorectal Cancer - N/A
- Locally advanced or metastatic Colorectal Cancer MedDRA version: 9.1 Level: PT Classification code 10061451 Term: Colorectal cancer
- Austria, France, Germany, Italy
- 2007-10-22